BioSpace News Archive

64x Bio , a synthetic biology company, today announced the close of a $55 million Series A financing round to fund the expansion of its VectorSelect™ platform.

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today the publication of a new peer-reviewed study analyzing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication adjunct, treatment of migraine.

Predicine, a global molecular insights company, announced today that it has appointed Clint Webb as its new General Counsel (GC).

Selexis SA , a JSR Life Sciences company, and Inotrem SA , an advanced clinical-stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, have signed a service agreement to develop the cell line for Inotrem’s antibody-based candidate to address chronic inflammations.

Neurovation Labs, Inc., a biotech company targeting physical biomarkers of PTSD for comprehensive diagnosis and treatment, today announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 11,224,668, on January 18, 2022.

NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a latest round of financing.

Neurophth Therapeutics, Inc., today announced receiving the U.S. Food and Drug Administration (FDA) clearance of its investigational new drug (IND) application on the in-vivo gene replacement therapy NR082 (rAAV2- ND4 ).

Adimab, LLC today announced that 12 new partner programs entered clinical development in 2021.

COVID-19 patients with newly diagnosed SARS-CoV-2 infections were treated in these randomized, double-blind, placebo-controlled Phase 2 trials in the US and UK.

Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, will host a virtual presentation of its poster at the American Society of Clinical Oncology’s (ASCO) Gastrointestinal Cancers Symposium being held from January 20-22, 2022, at the Moscone West Building in San Francisco, CA.